Latest filing published 20 Sept 2021 for Sprint Bioscience AB, €1,707.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jan Erik Nyström: trading record in brief
Jan Erik Nyström discloses dealings in Sprint Bioscience AB to Finansinspektionen. Between 24 June 2020 and 20 September 2021, the trades on record add up to 4 filings.
Purchases make up the whole of the open-market record (3 purchases, €11k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. 2021 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €4,771.
The newest entry dates from 20 September 2021: an open-market purchase of €1,707, in Sprint Bioscience AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Jan Erik Nyström
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,726 shares@ SEK 4.6630.1% of flowAktieISIN SE0006343745FI:csv-2e6cbd01e0489670e35fCanonical exit: 19 Dec 2021 (T+90)
- 7,550 shares@ SEK 5.3469.9% of flowBTA (betald tecknad aktie)ISIN SE0006343745FI:csv-cb9f5ab7e3d2f793b80b
- 2,517 shares@ SEK 20.00100.0% of flowBTU (betald tecknad unit)FI:csv-c77ca1354506cb53a608Canonical exit: 22 Sept 2020 (T+90)
3 of 3 declarations